相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effective targeting of the ubiquitin-like modifier NEDD8 for lung adenocarcinoma treatment
Yanyu Jiang et al.
CELL BIOLOGY AND TOXICOLOGY (2020)
Neddylation inhibition activates the protective autophagy through NF-κB-catalase-ATF3 Axis in human esophageal cancer cells
Yupei Liang et al.
CELL COMMUNICATION AND SIGNALING (2020)
Chemokines and chemokine receptors: A new strategy for breast cancer therapy
Hui Liu et al.
CANCER MEDICINE (2020)
NEDD8-conjugating enzyme UBC12 as a novel therapeutic target in esophageal squamous cell carcinoma
Shiwen Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Neddylation: a novel modulator of the tumor microenvironment
Lisha Zhou et al.
MOLECULAR CANCER (2019)
Promotion of tumor-associated macrophages infiltration by elevated neddylation pathway via NF-kappa B-CCL2 signaling in lung cancer
Lisha Zhou et al.
ONCOGENE (2019)
Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer
Lihui Li et al.
EBIOMEDICINE (2019)
Neural precursor cell expressed, developmentally downregulated 8 promotes tumor progression and predicts poor prognosis of patients with bladder cancer
Da-Wei Tian et al.
CANCER SCIENCE (2019)
Macrophages as regulators of tumour immunity and immunotherapy
David G. DeNardo et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
Ronan T. Swords et al.
BLOOD (2018)
Protein neddylation and its alterations in human cancers for targeted therapy
Lisha Zhou et al.
CELLULAR SIGNALLING (2018)
Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients
Wei-jie Zhang et al.
JOURNAL OF SURGICAL RESEARCH (2018)
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Adam Nagy et al.
SCIENTIFIC REPORTS (2018)
Overactivated neddylation pathway in human hepatocellular carcinoma
Jian Yu et al.
CANCER MEDICINE (2018)
Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1
Ya-Ling Hsu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-kappa B/SOX4 signaling
Neng Wang et al.
CELL DEATH & DISEASE (2018)
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
Otilia Menyhart et al.
ROYAL SOCIETY OPEN SCIENCE (2018)
Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
Xiaoguang Li et al.
GUT (2017)
Tumor-associated macrophages: implications in cancer immunotherapy
Amy J. Petty et al.
IMMUNOTHERAPY (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
CCL2/CCR2 signaling pathway in glioblastoma multiforme
Alireza Vakilian et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas
D. Yan et al.
ONCOGENE (2017)
Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo
Yaw Asare et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target
Ping Xie et al.
CELL DEATH & DISEASE (2017)
Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature
Xixi Zhao et al.
ONCOTARGET (2017)
The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2
Dimitry A. Chistiakov et al.
IMMUNOBIOLOGY (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Nedd8 modification of Cullin-5 regulates lipopolysaccharide-induced acute lung injury
Ziyan Zhu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Cc13
Elena Farmaki et al.
CANCER LETTERS (2017)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma
Shailender Bhatia et al.
INVESTIGATIONAL NEW DRUGS (2016)
Cutting Edge: A Cullin-5-TRAF6 Interaction Promotes TRAF6 Polyubiquitination and Lipopolysaccharide Signaling
Ziyan Zhu et al.
JOURNAL OF IMMUNOLOGY (2016)
CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer
Makito Miyake et al.
NEOPLASIA (2016)
Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside
Masahisa Jinushi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study
Ronan T. Swords et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Protein neddylation: beyond cullin-RING ligases
Radoslav I. Enchev et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Suppression of glioblastoma by targeting the overactivated protein neddylation pathway
Wei Hua et al.
NEURO-ONCOLOGY (2015)
Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy
Yongchao Zhao et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Ubiquitination by SAG regulates macrophage survival/death and immune response during infection
S. C. Chang et al.
CELL DEATH AND DIFFERENTIATION (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer
Lihui Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers
Balazs Gyorffy et al.
MOLECULAR ONCOLOGY (2014)
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Laura Bonapace et al.
NATURE (2014)
Neddylation pathway regulates the proliferation and survival of macrophages
Lihui Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Cullin-RING Ligases as Attractive Anti-cancer Targets
Yongchao Zhao et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
Kouji Izumi et al.
EMBO MOLECULAR MEDICINE (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
Endothelial CCR2 Signaling Induced by Colon Carcinoma Cells Enables Extravasation via the JAK2-Stat5 and p38MAPK Pathway
Monika Julia Wolf et al.
CANCER CELL (2012)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
Biochemical regulation of the inflammasome
Jennifer K. Dowling et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
SCF E3 Ubiquitin Ligases as Anticancer Targets
L. Jia et al.
CURRENT CANCER DRUG TARGETS (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Molecular Pathways Linking Inflammation and Cancer
A. Mantovani
CURRENT MOLECULAR MEDICINE (2010)
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
James E. Brownell et al.
MOLECULAR CELL (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
RING Domain E3 Ubiquitin Ligases
Raymond J. Deshaies et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Ubiquitylation in innate and adaptive immunity
Vijay G. Bhoj et al.
NATURE (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
Molecular mechanisms involved in inflammasome activation
Clare Bryant et al.
TRENDS IN CELL BIOLOGY (2009)
MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells:: involvement of nuclear factor-κB and activator protein-1
Pablo C. Ortiz-Lazareno et al.
IMMUNOLOGY (2008)
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression
Fernando O. Martinez et al.
JOURNAL OF IMMUNOLOGY (2006)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD8's E1
DT Huang et al.
MOLECULAR CELL (2005)
Function and regulation of Cullin-RING ubiquitin ligases
MD Petroski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
分享论文
